Cygnal. Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 56

Employees

  • Latest Deal Type
  • M&A

Cygnal. General Information

Description

Operator of a drug discovery platform intended to offer drugs to manipulate and exonerate biology for the treatment of cancer. The company's platform offers novel therapeutics for the treatment of immunological diseases and regenerative processes, enabling clients to receive exonerate treatment for various sorts of cancer-related diseases.

Contact Information

Website
www.cygnaltx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 325 Vassar Street
  • Suite 2B
  • Cambridge, MA 02139
  • United States
+1 (877)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Sonata Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 325 Vassar Street
  • Suite 2B
  • Cambridge, MA 02139
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cygnal. Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 18-May-2022 Completed Generating Revenue
4. Later Stage VC (Series C) 30-Sep-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 08-Oct-2019 Completed Generating Revenue
2. Debt Refinancing 12-Jan-2018 $6M $20.4M Completed Startup
1. Early Stage VC (Series A) 15-May-2017 $14.4M $14.4M Completed Startup
To view Cygnal.’s complete valuation and funding history, request access »

Cygnal. Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 12,973,466 $0.001000 $1.5 $1.5 1x $1.5 34.53%
To view Cygnal.’s complete cap table history, request access »

Cygnal. Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cygnal. Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
BEST Funds Venture Capital Minority
Costella Kirsch Venture Capital Minority
Flagship Pioneering Venture Capital Minority
To view Cygnal.’s complete investors history, request access »

Cygnal. Acquisitions (1)

Cygnal.’s most recent deal was a Merger of Equals with Sonata Therapeutics. The deal was made on 18-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sonata Therapeutics 18-May-2022 Merger of Equals Drug Discovery
To view Cygnal.’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Cygnal. FAQs

  • When was Cygnal. founded?

    Cygnal. was founded in 2017.

  • Where is Cygnal. headquartered?

    Cygnal. is headquartered in Cambridge, MA.

  • What is the size of Cygnal.?

    Cygnal. has 56 total employees.

  • What industry is Cygnal. in?

    Cygnal.’s primary industry is Drug Discovery.

  • Is Cygnal. a private or public company?

    Cygnal. is a Private company.

  • What is Cygnal.’s current revenue?

    The current revenue for Cygnal. is .

  • How much funding has Cygnal. raised over time?

    Cygnal. has raised $160M.

  • Who are Cygnal.’s investors?

    ACS BrightEdge, BEST Funds, Costella Kirsch, and Flagship Pioneering have invested in Cygnal..

  • When was Cygnal. acquired?

    Cygnal. was acquired on 18-May-2022.

  • Who acquired Cygnal.?

    Cygnal. was acquired by Sonata Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process